Skip to main content
AV

Atlante Ventures

Venture CapitalTurin, ItalySee on the map

medtechneurotech

Atlante Ventures is the venture capital arm of the Intesa Sanpaolo Group. It invested in a medtech startup developing deep-brain stimulation technology for Parkinson’s disease.

2
Portfolio companies on reccy
1
Hiring now
2
Open roles in the portfolio
Sep 2019
Latest portfolio round

Hiring now in the portfolio2

Portfolio on reccy2

Their companies, round by round

  • NewronikaMilan, Italy

    Brain-computer interfaces · Neuromodulation

    • Feb 2025Series B · $14.2M
    • Mar 2023Grant · $5.1M
    • Dec 2022Grant · $2.7M
    • Sep 2022Grant · $4.5M
    • Sep 2019Series A · $9.2MLed
    • Jun 2016Venture Round · $1.9M
  • Wisene Ltd.Cologno Monzese, Italy

    EEG and neural monitoring · Neuromodulation

    • Jul 2024Series D · $32.4M
    • Jul 2024Debt Financing
    • Oct 2020Series C · $17.6M
    • Jan 2019Grant · $82K
    • May 2017Series B · $7.3M
    • Jun 2015Series A · $3.4M

Rounds marked Led list Atlante Ventures as a lead investor; the rest are the company's other funding.

Recent rounds in the portfolio

Portfolio in the news